RAMP1 and acute myeloid leukemia: The impact of CGRP on drug resistance in AML may be underestimated in these cell line models, because araC increased the expression of the CALCRL and RAMP1 mRNAs in patient samples (Figure 1b), but not in the cell lines (Figure S5).